NWG vs. GSK
Compare and contrast key facts about NatWest Group plc (NWG) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NWG or GSK.
Correlation
The correlation between NWG and GSK is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NWG vs. GSK - Performance Comparison
Key characteristics
NWG:
2.80
GSK:
-0.53
NWG:
3.46
GSK:
-0.61
NWG:
1.45
GSK:
0.92
NWG:
0.84
GSK:
-0.45
NWG:
21.35
GSK:
-0.89
NWG:
3.79%
GSK:
12.90%
NWG:
28.92%
GSK:
21.74%
NWG:
-98.38%
GSK:
-55.21%
NWG:
-91.53%
GSK:
-24.73%
Fundamentals
NWG:
$40.90B
GSK:
$69.30B
NWG:
$1.29
GSK:
$1.52
NWG:
7.88
GSK:
22.20
NWG:
0.55
GSK:
0.77
NWG:
$18.27B
GSK:
$23.26B
NWG:
$21.88B
GSK:
$16.84B
NWG:
$1.68B
GSK:
$6.82B
Returns By Period
In the year-to-date period, NWG achieves a -3.24% return, which is significantly lower than GSK's -0.21% return. Over the past 10 years, NWG has outperformed GSK with an annualized return of 2.94%, while GSK has yielded a comparatively lower 2.47% annualized return.
NWG
-3.24%
-7.08%
18.55%
84.76%
16.48%
2.94%
GSK
-0.21%
-6.22%
-10.64%
-11.76%
-2.36%
2.47%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NWG vs. GSK — Risk-Adjusted Performance Rank
NWG
GSK
NWG vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for NatWest Group plc (NWG) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NWG vs. GSK - Dividend Comparison
NWG's dividend yield for the trailing twelve months is around 4.51%, less than GSK's 4.61% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NWG NatWest Group plc | 4.51% | 4.37% | 9.24% | 11.32% | 2.73% | 4.58% | 9.76% | 0.91% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 4.61% | 4.60% | 3.75% | 4.78% | 4.92% | 5.49% | 4.28% | 5.55% | 5.72% | 7.06% | 5.96% | 6.09% |
Drawdowns
NWG vs. GSK - Drawdown Comparison
The maximum NWG drawdown since its inception was -98.38%, which is greater than GSK's maximum drawdown of -55.21%. Use the drawdown chart below to compare losses from any high point for NWG and GSK. For additional features, visit the drawdowns tool.
Volatility
NWG vs. GSK - Volatility Comparison
The current volatility for NatWest Group plc (NWG) is 6.42%, while GlaxoSmithKline plc (GSK) has a volatility of 6.80%. This indicates that NWG experiences smaller price fluctuations and is considered to be less risky than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NWG vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between NatWest Group plc and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities